Your State:
Bookmark the new Broker Launchpad – guiding you to the right tool at the right time.
With 5 being the highest, how would you rate your experience on a scale of 1-5?
Feb 28, 2024
The maker of Levemir FlexPens and vials will stop making the man-made insulin this year. Flexpens will be discontinued on April 1, 2024. Vials of the drug will be discontinued on December 31, 2024. CarelonRx will be notifying roughly 5,000 members who have recently filled Levemir by March 1, 2024, to tell them about the discontinuation and alternative insulins covered by their plan. Levemir will be removed from most of Anthem’s commercial formularies on April 1, 2024, and all existing users will be grandfathered.
No formulary changes will be made to the 2023 and 2024 fully insured CT and NY formularies. Traditional and Complete formularies will have Levemir moved to tier 3. Select, Custom BCI, Mercy, and AlohaCare formularies are not impacted.
We will notify Anthem groups and provide a sample of the member communication.
Small Businesses are the engine that drives communities across America. This month we honor and celebrate those businesses and commit to our continuing collaboration to build healthy communities where people and businesses thrive. We recently shared this small-business video with your client gro...
Ohio law requires insurers offering health care plans through a health insurance exchange to make the following information available to existing and potential members upon request: A list of the top 20% of services based on use An insured's expected contribution for each service The top 20...